Inhibition of Hatching of Mouse Blastocysts in vitro by Prostaglandin Antagonists
The escape of the blastocyst from the zona pellucida in vitro is probably the result of expansion due to fluid accumulation in the blastocoele. This fluid accumulation is mediated by the epithelial trophectoderm. Since prostaglandins of the E series are involved in the control of water movement acro...
Gespeichert in:
Veröffentlicht in: | Biology of reproduction 1978-10, Vol.19 (3), p.519-533 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The escape of the blastocyst from the zona pellucida in vitro is probably the result of expansion
due to fluid accumulation in the blastocoele. This fluid accumulation is mediated by the
epithelial trophectoderm. Since prostaglandins of the E series are involved in the control of water
movement across epithelia, the effect of prostaglandin antagonists on the hatching of mouse
blastocysts has been examined. Protein-free culture media have been used to overcome the complicating
effects of protein bindings of the drugs on their activities. 7-Oxa-13-prostynoic acid, meclofenamic
acid, indomethacin and pheniodone inhibit hatching, but the properties of their dose-response
lines vary. 7-Oxa-13-prostynoic acid and meclofenamic acid have steep dose-response lines. The median
inhibitory doses (ID50s) and confidence limits (P = 0.05) are: 7-oxa-13-prostynoic acid 0.81µ
M (0.55-1.20); meclofenamic acid 7.72 µM (3.43-17.4). Indomethacin and phenidone have
very flat dose-response lines indicating wide variability of response. The ID50s and the confidence
limits are: indomethacin 9.08 µM (1-67); phenidone 20 µM (92-263). Thus, 7-oxa-13-prostynoic
acid has much greater activity than the other three compounds. The results provide circumstantial
evidence that endogenous prostaglandins are involved in blastocyst expansion and may play a role
in the process of implantation. Interference with blastocyst expansion with antiprostaglandins
administered in a medicated I.U.D. may be a useful means of contraception. |
---|---|
ISSN: | 0006-3363 1529-7268 |
DOI: | 10.1095/biolreprod19.3.519 |